Evaluation of the risk of acute kidney injury with the use of piperacillin/tazobactam among adult critically ill patients.
Mohamed Omar SaadAdham M MohamedHassan A MitwallyAhmed A ShibleAli Ait HssainMohamed A AbdelatyPublished in: Infection (2020)
In this study, PT was not associated with a higher risk of AKI compared to cefepime or meropenem among adult critically ill patients.